menu

Menu

Home Aims and Scope statement Editorial board Instructions for authors Statement of Informed consent Statement of Human and Animal Rights Editorial process and peer review Copyright and License - Index and Abstract service - Open Access How to submit your article Contacts Archive

Latest Articles

PAG. 2193.
Medica 3 / 2022

MANAGEMENT OF PATIENTS WITH ALLERGIC RHINITIS IN THE PRIMARY CARE SETTING: A CROSS-SECTIONAL MULTICENTER STUDY IN DAILY PRACTICE (THE MAPRAP STUDY)

PAG. 1725.
Medica 3 / 2022

COVID-19 AS A HEALTH EDUCATION CHALLENGE: A PERSPECTIVE CROSS-SECTIONAL STUDY

PAG. 1719.
Medica 3 / 2022

Effect of lamivudine combined with thymosin on postoperative recurrence of alcoholic hepatitis complicated with liver cancer

You are here: Archive 2017 Medica 5 Pag 777

KETOGENIC DIET AS ANTIEPILEPTIC THERAPY: NEUROTRASMISSION EFFECTS

  Pdf

Authors

AGATA MALTESE1, MARGHERITA SALERNO2, PALMIRA ROMANO3, ANNACLAUDIA RICCIARDI3, TERESA DI FILIPPO, GABRIELE TRIPI4,5

Departments

AGATA MALTESE1, MARGHERITA SALERNO2, PALMIRA ROMANO3, ANNACLAUDIA RICCIARDI3, TERESA DI FILIPPO, GABRIELE TRIPI4,5

Abstract

The Ketogenic diet (KD) presents many effects on neurostrasmitters pathways.

KD may act on potassium channels sensitive to ATP (KATP), inhibiting rapamycin pathway in mammalians or glutamatergic synaptic transmission or mediated by peptide hormones.

Keywords

ketogenic diet, epilepsy, cholesterol, free fatty acids

DOI:

10.19193/0393-6384_2017_5_114

Back